Kalypsys provides drug discovery and development services.
Kalypsys provides pathway-based drug discovery and development services. The company implements discovery programs across a broad number of therapeutic areas using its automated and integrated suite of discovery technologies in biology, chemistry and informatics.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Aug 5, 2004 | Series B | $29M | 1 | Invemed Catalyst Fund | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Invemed Catalyst Fund | Yes | Series B |